DWM
TEVA icon

Drive Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

Drive Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Buy
7,161
+237
+3% +$7.89K 0.04% 363
2026
Q1 		$209K Sell
6,924
-1,030
-13% -$33.1K 0.04% 344
2025
Q4 		$248K Buy
+7,954
New +$196K 0.05% 304

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Drive Wealth Management's TEVA Position: Q2 2026 in Review

Drive Wealth Management increased its Teva Pharmaceuticals (TEVA) stake by 3.4% in Q2 2026, buying an estimated $7.89K and bringing the position to 7,161 shares worth $243K. The position accounts for 0.04% of the portfolio, ranked #363.

Drive Wealth Management first reported a position in TEVA in Q4 2025 and has held it in 3 quarters since. The position peaked at $248K in Q4 2025. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Drive Wealth Management held 7,161 shares of Teva Pharmaceuticals worth $243K as of Q2 2026.
  • Drive Wealth Management bought 237 Teva Pharmaceuticals shares in Q2 2026, an estimated $7.89K.
  • Teva Pharmaceuticals made up 0.04% of Drive Wealth Management's portfolio in Q2 2026, its #363 holding.
  • Drive Wealth Management first reported a position in Teva Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Drive Wealth Management's Teva Pharmaceuticals position peaked at $248K in Q4 2025.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Drive Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.